A new ruthenium(II)-catalyzed tandem C-H activation/cyclization/hydrolysis cascade process of 2 H-imidazoles and alkynes for facile and regioselective access to α-ketone-isoquinolines has been successfully developed. 2 H-Imidazole as the novel traceless directing group has been well applied in this paper. The protocol features mild reaction conditions and easily accessible starting materials, and α-ketone-isoquinolines could be applied to further construct more complex heterocyclic compounds.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: